A Daily Network publication
Explore the network
ETF Daily
The Definitive Daily Read on Exchange-Traded Funds
Thursday, October 8, 2026The Morning Brief →Sign in
ETF PRO AIOctober 8, 2026

BBH VanEck Biotech ETF

Fund tearsheet · data as of the latest session · October 8, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$483Mfund assets
+25.7%return, YTD
+36.4%return, 1 year
−$5Mnet flow, 1 month
−$21Mnet flow, 1 year
21.6%realized volatility, 1y
-10.5%worst drawdown, 1y
Top ten holdings
1AMGN AMGEN15.33%
2GILD GILEAD SCIENCES13.00%
3VRTX VERTEX PHARMACEUTICALS8.04%
4REGN REGENERON PHARMACEUTICALS6.33%
5MRNA MODERNA6.50%
6NTRA NATERA5.59%
7ARGX ARGENX SE4.44%
8IQV IQVIA HOLDINGS4.49%
9RVMD REVOLUTION MEDICINES4.34%
10ILMN ILLUMINA4.41%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

Every weekday · 6:30 a.m. ET

The Morning Brief

ETF launches, fund research, and market coverage in your inbox every weekday. Free.